More on Minerva Q2 results

Minerva Neurosciences (NERV +2.6%) Q2 results: Revnues: $0; Operating Expenses: $17.7M (+999%); Net Loss: ($19.4M) (-999%); Loss Per Share: ($2.55) (-999%); Quick Assets: $480K (-73.6%).

No guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs